A 3-month provider-prescribed compounded tirzepatide injectable bundle for women seeking weight management support during midlife. A licensed provider reviews your intake before determining whether treatment is appropriate. Compounded tirzepatide is not FDA-approved. An $80 consult fee may apply if you don’t move forward after provider review.
Josie’s Compounded Tirzepatide 3-Month Bundle is a full-dose injectable care option for women seeking provider-led weight management support during perimenopause, menopause, or postmenopause.
This care path is designed for women who are actively working on weight management and want medical oversight before starting treatment.
A licensed provider reviews your intake, health history, current medications, goals, and eligibility before deciding whether compounded tirzepatide is appropriate.
Completing the intake form does not guarantee a prescription.
The Compounded Tirzepatide 3-Month Bundle may be considered for women who want provider-led weight management support during midlife.
This may include women who:
This option is not appropriate for everyone.
A licensed provider must review your intake, health history, medications, and goals before deciding whether compounded tirzepatide treatment is medically appropriate.
Answer questions about your health history, current medications, weight history, goals, and current needs.
A licensed provider reviews your intake and determines whether compounded tirzepatide may be appropriate.
A prescription is only issued if your provider determines treatment is medically appropriate.
If prescribed, your medication is prepared and shipped by a U.S. compounding pharmacy.
Josie includes provider messaging and ongoing support so you can ask questions and stay connected to care.
If your intake is reviewed by a provider and you decide not to move forward with treatment after your consultation, an $80 consult fee may apply.
There is no separate $80 consult fee if you move forward with the prescribed medication.
Compounded tirzepatide is not FDA-approved. The FDA has not evaluated compounded medications for safety, effectiveness, or quality.
GLP-1 medications are prescription medications and should only be used under the supervision of a licensed healthcare provider.
GLP-1 medications may carry serious risks and may not be appropriate for everyone. Your provider will review your health history, medications, goals, and possible risks before making a prescribing decision.
Josie is not a compounding pharmacy. If prescribed, medication is prepared and shipped by a U.S. compounding pharmacy.
Yes. This is a full-dose compounded tirzepatide injectable care path for women seeking provider-led weight management support.
No. This is not Josie’s microdose care path. This is a full-dose compounded tirzepatide injectable option for weight management support.
No. Compounded tirzepatide is not FDA-approved. The FDA has not evaluated compounded medications for safety, effectiveness, or quality.
If prescribed, the 3-month bundle provides a longer supply format for compounded tirzepatide injectable care. Your provider gives dosing instructions based on your treatment plan.
No. Completing the intake form does not guarantee a prescription. A licensed provider determines whether treatment is appropriate.
No. Josie is not a compounding pharmacy. If prescribed, medication is prepared and shipped by a U.S. compounding pharmacy.
A licensed provider reviews your intake, health history, current medications, goals, and eligibility before deciding whether treatment is appropriate.
If your intake is reviewed and you decide not to move forward with treatment after your consultation, an $80 consult fee may apply. There is no separate $80 consult fee if you move forward with the prescribed medication.
Complete your intake so a licensed provider can review whether compounded tirzepatide injectable care may be appropriate for your health history and goals.
Josie’s Compounded Tirzepatide 3-Month Bundle is a full-dose injectable care option for women seeking provider-led weight management support during perimenopause, menopause, or postmenopause.
This care path is designed for women who are actively working on weight management and want medical oversight before starting treatment.
A licensed provider reviews your intake, health history, current medications, goals, and eligibility before deciding whether compounded tirzepatide is appropriate.
Completing the intake form does not guarantee a prescription.
The Compounded Tirzepatide 3-Month Bundle may be considered for women who want provider-led weight management support during midlife.
This may include women who:
This option is not appropriate for everyone.
A licensed provider must review your intake, health history, medications, and goals before deciding whether compounded tirzepatide treatment is medically appropriate.
Answer questions about your health history, current medications, weight history, goals, and current needs.
A licensed provider reviews your intake and determines whether compounded tirzepatide may be appropriate.
A prescription is only issued if your provider determines treatment is medically appropriate.
If prescribed, your medication is prepared and shipped by a U.S. compounding pharmacy.
Josie includes provider messaging and ongoing support so you can ask questions and stay connected to care.
If your intake is reviewed by a provider and you decide not to move forward with treatment after your consultation, an $80 consult fee may apply.
There is no separate $80 consult fee if you move forward with the prescribed medication.
Compounded tirzepatide is not FDA-approved. The FDA has not evaluated compounded medications for safety, effectiveness, or quality.
GLP-1 medications are prescription medications and should only be used under the supervision of a licensed healthcare provider.
GLP-1 medications may carry serious risks and may not be appropriate for everyone. Your provider will review your health history, medications, goals, and possible risks before making a prescribing decision.
Josie is not a compounding pharmacy. If prescribed, medication is prepared and shipped by a U.S. compounding pharmacy.
Yes. This is a full-dose compounded tirzepatide injectable care path for women seeking provider-led weight management support.
No. This is not Josie’s microdose care path. This is a full-dose compounded tirzepatide injectable option for weight management support.
No. Compounded tirzepatide is not FDA-approved. The FDA has not evaluated compounded medications for safety, effectiveness, or quality.
If prescribed, the 3-month bundle provides a longer supply format for compounded tirzepatide injectable care. Your provider gives dosing instructions based on your treatment plan.
No. Completing the intake form does not guarantee a prescription. A licensed provider determines whether treatment is appropriate.
No. Josie is not a compounding pharmacy. If prescribed, medication is prepared and shipped by a U.S. compounding pharmacy.
A licensed provider reviews your intake, health history, current medications, goals, and eligibility before deciding whether treatment is appropriate.
If your intake is reviewed and you decide not to move forward with treatment after your consultation, an $80 consult fee may apply. There is no separate $80 consult fee if you move forward with the prescribed medication.
Complete your intake so a licensed provider can review whether compounded tirzepatide injectable care may be appropriate for your health history and goals.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript